However, the degree of foam cell formation did not change after treatment with Gal-3 siRNA (Supplement Figure 1), suggesting that CML promoted foam cell formation via RAGE. The gene discussed is LGALS3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.